LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,096 | +69766.7% | 510 | +50900.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $33,000 | -19.5% | 8,085 | -14.3% | 0.00% | – |
| Q4 2021 | $41,000 | -85.1% | 9,431 | -68.7% | 0.00% | – |
| Q3 2021 | $275,000 | -59.9% | 30,163 | -64.7% | 0.00% | – |
| Q2 2021 | $685,000 | -44.8% | 85,411 | -20.3% | 0.00% | – |
| Q1 2021 | $1,242,000 | +666.7% | 107,217 | +655.0% | 0.00% | – |
| Q4 2020 | $162,000 | +1925.0% | 14,201 | +1979.2% | 0.00% | – |
| Q3 2020 | $8,000 | -55.6% | 683 | -56.9% | 0.00% | – |
| Q2 2020 | $18,000 | – | 1,583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|